Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TYMP | P19971 | 6/20 | 0.50 |
| ▸ | PRMT6 | Q96LA8 | 1/20 | 0.44 |
| ▸ | ADORA1 | P30542 | 3/20 | 0.42 |
| ▸ | P2RY12 | Q9H244 | 1/20 | 0.41 |
| ▸ | ADORA2A | P29274 | 1/20 | 0.41 |
| ▸ | ADORA2B | P29275 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8380846 | 0.97 | TYMP (0.51) | TYMPPRMT6ADORA1P2RY12ADORA2A | |
| SCHEMBL20482910 | 0.93 | TYMP (0.55) | TYMPADORA1P2RY12ADORA2AADORA2B | |
| SCHEMBL21591934 | 0.93 | TYMP (0.55) | TYMPADORA1P2RY12ADORA2AADORA2B | |
| SCHEMBL8385935 | 0.93 | TYMP (0.55) | TYMPADORA1P2RY12ADORA2AADORA2B | |
| SCHEMBL8385934 | 0.93 | TYMP (0.55) | TYMPADORA1P2RY12ADORA2AADORA2B | |
| SCHEMBL29814199 | 0.93 | TYMP (0.55) | TYMPADORA1P2RY12ADORA2AADORA2B | |
| SCHEMBL19493438 | 0.93 | TYMP (0.55) | TYMPPRMT6ADORA1P2RY12ADORA2A | |
| SCHEMBL21305068 | 0.93 | TYMP (0.55) | TYMPPRMT6ADORA1P2RY12ADORA2A | |
| SCHEMBL6396836 | 0.93 | TYMP (0.55) | TYMPPRMT6ADORA1P2RY12ADORA2A | |
| SCHEMBL8381924 | 0.93 | TYMP (0.55) | TYMPPRMT6ADORA1P2RY12ADORA2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4277636-A1 | MODIFIED OLIGONUCLEOTIDES | Alnylam Pharmaceuticals, Inc. (US) | 2023-11-22 | — | — | EP | disclosed |
| WO-2022155418-A1 | MODIFIED OLIGONUCLEOTIDES | ALNYLAM PHARMACEUTICALS, INC. (US) | 2022-07-21 | — | — | WO | disclosed |